- Inability to attract and retain suitably qualified team members as the Company continues to grow
- Extensive legislative, regulatory and other requirements both during clinical development and commercialization and post-marketing approval
- Hazardous materials are used in operations and may be used by our partners and suppliers and must comply with environmental laws and regulations
- Inability to manage the carbon footprint from our business operations or climate-related events may impact our business operations or that of our third-party partners or suppliers
- Primarily dependent on one contract manufacturing organization and individual sites at the CMO to produce and supply our product candidates
- Risks associated with global health crises, epidemics, pandemics and other outbreaks
Genmab A/S
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Genmab A/S disclosed greenhouse gas emissions of 147.7K tCO2e (2022). By scope: Scope 1: 317 tCO2e (2023); Scope 2: 238 tCO2e (2023); Scope 3: 147.3K tCO2e (2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
147.7K tCO2e (2022)
2023
Renewable Energy
76.8% (2023)
of total energy
Energy Use
3.3K MWh (2023)
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 317 tCO2e (2023) |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 238 tCO2e (2023) |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 147.3K tCO2e (2022) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Completed our first full carbon footprint assessment of Scope 1, 2, and 3 GHG emissions
- Opened laboratories and facilities in BREEAM Excellent certified Accelerator building in the Netherlands
- Applied adaptive re-use of office space at two sites
- Implemented solution to enable re-use of plastic pipette tips
🎯 Climate & Sustainability Targets
🔜 Short-term
- Achieve a 42% reduction in Scope 1 and 2 GHG by 2030 compared to a 2021 baseline year
📅 Medium-term
- Reduce Scope 3 emissions by 2030 through supplier engagement and responsible sourcing practices by having at least two-thirds of our suppliers, by spend, covered by Paris Agreement aligned climate targets
🌱 ESG Focus Areas
Good Health and Well-beingGender EqualityDecent Work and Economic GrowthClimate Action